CBD shows promise for opioid addiction and pain relief in small study
NCT ID NCT05076370
First seen Jan 03, 2026 · Last updated Apr 30, 2026 · Updated 14 times
Summary
This early-stage study tested whether cannabidiol (CBD) could safely help people with both opioid addiction and chronic pain. Seven adults on methadone or buprenorphine received CBD or a placebo in a crossover design. Researchers measured sedation, cognitive function, side effects, and pain sensitivity. The goal was to see if CBD could reduce opioid cravings and pain without major side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADDICTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Veteran Affairs Hospital
West Haven, Connecticut, 06516, United States
Conditions
Explore the condition pages connected to this study.